Metraipolis › archive › dc_d2c20e64e3bb
The global epidemiology of chikungunya from 1999 to 2020: A systematic literature review to inform the development and introduction of vaccines — Europe PMC PMID:35020717
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/35020717
- DOI
- 10.1371/journal.pntd.0010069
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-31T15:29:19.688Z
- SHA-256 of the archived text
5534d42c43cfa14080859bc70022c043f2817e75b0d1d0a34909956da0bbcdf2- Stable URL of this page
https://metraipolis.com/documento/dc_d2c20e64e3bb
How to cite
The global epidemiology of chikungunya from 1999 to 2020: A systematic literature review to inform the development and introduction of vaccines — Europe PMC PMID:35020717 — Europe PMC (en), https://europepmc.org/article/MED/35020717 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_d2c20e64e3bb (Metraipolis archive dc_d2c20e64e3bb, sha256 5534d42c43cfa14080859bc70022c043f2817e75b0d1d0a34909956da0bbcdf2)
BibTeX
@misc{dcd2c20e64e3bb,
title = {The global epidemiology of chikungunya from 1999 to 2020: A systematic literature review to inform the development and introduction of vaccines — Europe PMC PMID:35020717},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/35020717},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_d2c20e64e3bb; sha256 5534d42c43cfa14080859bc70022c043f2817e75b0d1d0a34909956da0bbcdf2},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/35020717. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Chikungunya fever is an acute febrile illness that is often associated with severe polyarthralgia in humans. The disease is caused by chikungunya virus (CHIKV), a mosquito-borne alphavirus. Since its reemergence in 2004, the virus has spread throughout the tropical world and several subtropical areas affecting millions of people to become a global public health issue. Given the significant disease burden, there is a need for medical countermeasures and several vaccine candidates are in clinical development. To characterize the global epidemiology of chikungunya and inform vaccine development, we undertook a systematic literature review in MEDLINE and additional public domain sources published up to June 13, 2020 and assessed epidemiological trends from 1999 to 2020. Observational studies addressing CHIKV epidemiology were included and studies not reporting primary data were excluded. Only descriptive analyses were conducted. Of 3,883 relevant sources identified, 371 were eligible for inclusion. 46% of the included studies were published after 2016. Ninety-seven outbreak reports from 45 countries and 50 seroprevalence studies from 31 countries were retrieved, including from Africa, Asia, Oceania, the Americas, and Europe. Several countries reported multiple outbreaks, but these were sporadic and unpredictable. Substantial gaps in epidemiological knowledge were identified, specifically granular data on disease incidence and age-specific infection rates. The retrieved studies revealed a diversity of methodologies and study designs, reflecting a lack of standardized procedures used to characterize this disease. Nevertheless, available epidemiological data emphasized the challenges to conduct vaccine efficacy trials due to disease unpredictability. A better understanding of chikungunya disease dynamics with appropriate granularity and better insights into the duration of long-term population immunity is critical to assist in the planning and success of vaccine development efforts pre and post licensure. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PLoS neglected tropical diseases, 2022 (prima pubblicazione 2022-01-12). Identificativi: PMID 35020717 · PMCID PMC8789145 · DOI 10.1371/journal.pntd.0010069. Descrittori MeSH principali: Vaccine Development. Pagina: https://europepmc.org/article/MED/35020717 — https://doi.org/10.1371/journal.pntd.0010069. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-10-31T15:21:22.794Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.